1498.HK实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 15:59):

Stats
今日成交量	402 500
平均成交量	47 152.00
市值	288.39M
EPS	HKD0 ( 2024-03-28 )
Last Dividend	HKD0.0191 ( 2017-05-31 )
Next Dividend	HKD0 ( N/A )
P/E	-2.70
ATR14	HKD0 (0.00%)

PuraPharm Corp Ltd 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

PuraPharm Corp Ltd 财务报表

Annual	2023
营收:	HKD406.86M
毛利润:	HKD214.85M (52.81 %)
EPS:	HKD-0.270

FY	2023
营收:	HKD406.86M
毛利润:	HKD214.85M (52.81 %)
EPS:	HKD-0.270

FY	2022
营收:	HKD448.07M
毛利润:	HKD260.59M (58.16 %)
EPS:	HKD-0.300

FY	2021
营收:	HKD659.59M
毛利润:	HKD423.35M (64.18 %)
EPS:	HKD-0.329

Financial Reports:

No articles found.

PuraPharm Corp Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

PuraPharm Corp Ltd Dividend Information - No Dividend Player

Dividend Sustainability Score: 0.0346 - low (50.00%) | Divividend Growth Potential Score: 1.387 - No dividend growth expected in the near future

Information

First Dividend	HKD0.0840	2016-05-19
Last Dividend	HKD0.0191	2017-05-31
Next Dividend	HKD0	N/A
Payout Date	2017-06-23
Next Payout Date	N/A
# dividends	2	--
Total Paid Out	HKD0.103	--
Avg. Dividend % Per Year	0.00%	--
Score	0.73	--
Div. Sustainability Score	0.0346
Div.Growth Potential Score	1.387
Div. Directional Score	0.711	--

Next Divdend (Est)
(2025-03-31)

HKD0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2314.HK	Ex Dividend Junior	2023-08-11	Semi-Annually	0.00%
1283.HK	Ex Dividend Junior	2023-09-22	Semi-Annually	0.00%
0341.HK	Ex Dividend Junior	2023-09-12	Annually	0.00%
6083.HK	Ex Dividend Knight	2023-06-12	Semi-Annually	0.00%
1843.HK	Ex Dividend Knight	2023-09-05	Annually	0.00%
0868.HK	Ex Dividend Knight	2023-08-11	Semi-Annually	0.00%
0016.HK	Ex Dividend Knight	2023-11-06	Semi-Annually	0.00%
2633.HK	Ex Dividend Knight	2023-08-15	Semi-Annually	0.00%
1412.HK	Ex Dividend Knight	2023-06-12	Semi-Annually	0.00%
0497.HK	Ex Dividend Junior	2023-08-25	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.261	1.500	-5.21	-7.82	[0 - 0.5]
returnOnAssetsTTM	-0.126	1.200	-4.19	-5.03	[0 - 0.3]
returnOnEquityTTM	-0.574	1.500	-7.49	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.612	0.800	-1.939	-1.552	[1 - 3]
quickRatioTTM	0.225	0.800	-3.38	-2.70	[0.8 - 2.5]
cashRatioTTM	0.0827	1.500	-0.652	-0.978	[0.2 - 2]
debtRatioTTM	0.478	-1.500	2.04	-3.06	[0 - 0.6]
interestCoverageTTM	-1.798	1.000	-1.777	-1.777	[3 - 30]
operatingCashFlowPerShareTTM	0.137	2.00	9.95	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0818	2.00	9.96	10.00	[0 - 20]
debtEquityRatioTTM	2.63	-1.500	10.00	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.528	1.000	4.53	4.53	[0.2 - 0.8]
operatingProfitMarginTTM	-0.121	1.000	-4.42	-4.42	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.134	1.000	-0.367	-0.367	[0.2 - 2]
assetTurnoverTTM	0.482	0.800	-0.119	-0.0956	[0.5 - 2]
Total Score				0.0346

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-2.72	1.000	-0.376	0	[1 - 100]
returnOnEquityTTM	-0.574	2.50	-4.81	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0818	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.137	2.00	9.95	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00588	1.500	-3.29	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.133	1.000	9.18	0	[0.1 - 0.5]
Total Score				1.387

PuraPharm Corp Ltd

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.